Fundz

Fundz Deep Dive

Everything you need to win The AbbVie Foundation and MATTER — in one platform.

Who to reach, what to say, and why now on The AbbVie Foundation and MATTER — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on The AbbVie Foundation and MATTER — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

AbbVie partners with EvolveImmune for developing cancer therapies

Oct 31, 2024•over 1 year ago

Contract Type

partnership

ChicagoHealth CareNon Profit

Description

AbbVie, a global biopharmaceutical company, has announced a collaboration with EvolveImmune Therapeutics, specializing in immunotherapy, to develop novel antibody-based therapies targeting solid and hematologic malignancies. The collaboration involves an option-to-license agreement and aims to utilize EvolveImmune's proprietary EVOLVE T-cell engager platform to enhance T-cell responses against tumors, addressing unmet needs in cancer treatment.

Company Information

Company

The AbbVie Foundation and MATTER

Location

Chicago, Illinois, United States

About

The AbbVie Foundation is a 501(c)(3) nonprofit working to drive transformative change and advance health equity. MATTER is the premier healthcare incubator and innovation hub.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for The AbbVie Foundation and MATTER's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.